Autopsy report · NCT00313690

Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer

“Recruitment difficulties”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

University of Southern California

Sponsor type

University, hospital or other

Conditions

Lung Cancer

Interventions

Bortezomib, Docetaxel and Cisplatin

Participants

0

Trials that died the same way

• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (99% match in meaning)
• Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
  “Difficulties in recruitment” (98% match in meaning)
• Alzheimer Disease : Rehabilitation's Intervention at Home
  “difficulties of recruitment” (98% match in meaning)
• Corneal Neurotization as a Treatment for Neurotrophic Keratopathy
  “Difficulties with recruitment” (97% match in meaning)
• The Cirrhosis Outpatient Optimization, Readmission & Safety Study
  “Increased recruitment difficulties” (96% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.